Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study

Background: Little is known about whether sarcopenia predicts incident depressive symptoms in older adults. Using the nationally representative data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted cross-sectional and longitudinal analyses to estimate the association be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ke Gao, Wen-Zhuo Ma, Scarlett Huck, Bo-Lin Li, Li Zhang, Jiao Zhu, Tian Li, Dan Zhou
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/7c12b435113c4db3bd6523b0c9311105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7c12b435113c4db3bd6523b0c9311105
record_format dspace
spelling oai:doaj.org-article:7c12b435113c4db3bd6523b0c93111052021-11-17T05:21:58ZAssociation Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study2296-858X10.3389/fmed.2021.755705https://doaj.org/article/7c12b435113c4db3bd6523b0c93111052021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.755705/fullhttps://doaj.org/toc/2296-858XBackground: Little is known about whether sarcopenia predicts incident depressive symptoms in older adults. Using the nationally representative data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted cross-sectional and longitudinal analyses to estimate the association between sarcopenia and depressive symptoms among older adults.Methods: The sample comprised 7,706 participants aged at least 60 years (50.6% women; mean age 68.0 ± 6.5) from the CHARLS 2015. Based on the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria, sarcopenia status was classified into three types: no-sarcopenia, possible sarcopenia, and sarcopenia. Depressive symptoms were assessed using the validated 10-items of the Center for Epidemiologic Studies Depression Scale. A cross-sectional analysis was used to examine the relationship between sarcopenia status and depressive symptoms. A total of 4,652 participants without depressive symptoms were recruited from the same cohort in 2015 and were followed up in 2018. Cox proportional hazards regression models were conducted to examine the effect of sarcopenia status on subsequent depressive symptoms with the report of hazard ratio (HR).Results: The prevalence of depressive symptoms in total populations, no-sarcopenia, possible sarcopenia, and sarcopenia individuals were 27.1% (2085/7706), 21.5% (927/4310), 33.6% (882/2627), and 35.9% (276/769), respectively. Both possible sarcopenia (OR: 1.75, 95% CI: 1.46–2.10) and sarcopenia (OR: 1.64, 95% CI: 1.23–2.19) were positively associated with higher odds of depressive symptoms (all p < 0.01). During the 3.7 years of follow-up, 956 cases (20.6%) with incident depressive symptoms were identified. In the longitudinal analysis, individuals with the diagnosed possible sarcopenia (HR: 1.27, 95% CI: 1.01–1.58) and sarcopenia participants (HR: 1.49, 95% CI: 1.06–2.09) were more likely to have new onset depressive symptoms than no-sarcopenia peers.Conclusions: Both possible sarcopenia and sarcopenia, assessed using the AWGS 2019 criteria, were independent predictors for the occurrence of depressive symptoms among Chinese older adults. Our findings provided new evidence supporting the longitudinal connection between sarcopenia and mental health problems, it also provides further justification for timely identification and management of both possible sarcopenia and sarcopenia as part of comprehensive strategies to fight against depressive symptoms.Ke GaoWen-Zhuo MaWen-Zhuo MaScarlett HuckBo-Lin LiLi ZhangJiao ZhuTian LiDan ZhouFrontiers Media S.A.articlesarcopeniapossible sarcopeniadepressive symptomslow muscle massolder adultsMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic sarcopenia
possible sarcopenia
depressive symptoms
low muscle mass
older adults
Medicine (General)
R5-920
spellingShingle sarcopenia
possible sarcopenia
depressive symptoms
low muscle mass
older adults
Medicine (General)
R5-920
Ke Gao
Wen-Zhuo Ma
Wen-Zhuo Ma
Scarlett Huck
Bo-Lin Li
Li Zhang
Jiao Zhu
Tian Li
Dan Zhou
Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
description Background: Little is known about whether sarcopenia predicts incident depressive symptoms in older adults. Using the nationally representative data from the China Health and Retirement Longitudinal Study (CHARLS), we conducted cross-sectional and longitudinal analyses to estimate the association between sarcopenia and depressive symptoms among older adults.Methods: The sample comprised 7,706 participants aged at least 60 years (50.6% women; mean age 68.0 ± 6.5) from the CHARLS 2015. Based on the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria, sarcopenia status was classified into three types: no-sarcopenia, possible sarcopenia, and sarcopenia. Depressive symptoms were assessed using the validated 10-items of the Center for Epidemiologic Studies Depression Scale. A cross-sectional analysis was used to examine the relationship between sarcopenia status and depressive symptoms. A total of 4,652 participants without depressive symptoms were recruited from the same cohort in 2015 and were followed up in 2018. Cox proportional hazards regression models were conducted to examine the effect of sarcopenia status on subsequent depressive symptoms with the report of hazard ratio (HR).Results: The prevalence of depressive symptoms in total populations, no-sarcopenia, possible sarcopenia, and sarcopenia individuals were 27.1% (2085/7706), 21.5% (927/4310), 33.6% (882/2627), and 35.9% (276/769), respectively. Both possible sarcopenia (OR: 1.75, 95% CI: 1.46–2.10) and sarcopenia (OR: 1.64, 95% CI: 1.23–2.19) were positively associated with higher odds of depressive symptoms (all p < 0.01). During the 3.7 years of follow-up, 956 cases (20.6%) with incident depressive symptoms were identified. In the longitudinal analysis, individuals with the diagnosed possible sarcopenia (HR: 1.27, 95% CI: 1.01–1.58) and sarcopenia participants (HR: 1.49, 95% CI: 1.06–2.09) were more likely to have new onset depressive symptoms than no-sarcopenia peers.Conclusions: Both possible sarcopenia and sarcopenia, assessed using the AWGS 2019 criteria, were independent predictors for the occurrence of depressive symptoms among Chinese older adults. Our findings provided new evidence supporting the longitudinal connection between sarcopenia and mental health problems, it also provides further justification for timely identification and management of both possible sarcopenia and sarcopenia as part of comprehensive strategies to fight against depressive symptoms.
format article
author Ke Gao
Wen-Zhuo Ma
Wen-Zhuo Ma
Scarlett Huck
Bo-Lin Li
Li Zhang
Jiao Zhu
Tian Li
Dan Zhou
author_facet Ke Gao
Wen-Zhuo Ma
Wen-Zhuo Ma
Scarlett Huck
Bo-Lin Li
Li Zhang
Jiao Zhu
Tian Li
Dan Zhou
author_sort Ke Gao
title Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
title_short Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
title_full Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
title_fullStr Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
title_full_unstemmed Association Between Sarcopenia and Depressive Symptoms in Chinese Older Adults: Evidence From the China Health and Retirement Longitudinal Study
title_sort association between sarcopenia and depressive symptoms in chinese older adults: evidence from the china health and retirement longitudinal study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/7c12b435113c4db3bd6523b0c9311105
work_keys_str_mv AT kegao associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT wenzhuoma associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT wenzhuoma associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT scarletthuck associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT bolinli associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT lizhang associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT jiaozhu associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT tianli associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
AT danzhou associationbetweensarcopeniaanddepressivesymptomsinchineseolderadultsevidencefromthechinahealthandretirementlongitudinalstudy
_version_ 1718425935161589760